UnitedHealth (UNH) PT Raised to $155 at FBR Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
UnitedHealth Group (UNH) PT Raised to $161 at Oppenheimer
July 20, 2016 9:54 AM EDTOppenheimer analyst Michael Wiederhorn reiterated an Outperform rating and bumped his price target on UnitedHealth Group (NYSE: UNH) to $161.00 (from $145.00) following solid Q2 results despite ACA challenges.
Wiederhorn commented, "UNH reported 2Q16 adjusted EPS of $1.96 (GAAP: $1.81, includes $0.15 amortization), vs. OPCO/Street of $1.91/$1.89.... More
UnitedHealth Group (UNH) PT Raised to $155 at Credit Suisse Post Q2
July 20, 2016 8:56 AM EDTCredit Suisse analyst S. Fidel reiterated an Outperform rating and lifted his price target on UnitedHealth Group (NYSE: UNH) to $155.00 (from $148.00) following Q2 results.
Fidel commented, "UNH's growth thesis continues to separate from the rest of the pack: While UNH's challenges in the public exchanges once again put a damper on an otherwise strong 2Q report, the company appears to be setting up increasingly well for 15%+ EPS growth in 2017. First, the planned exits... More
Leerink Partners Reiterates Outperform on UnitedHealth Group (UNH) Following 2Q Beat and Raise
July 20, 2016 7:18 AM EDTLeerink Partners reiterated an Outperform rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $165.00 (from $155.00), following the company's 2Q earnings report. UNH reported a 7c EPS beat and $1.5B revenue beat with a conservative EPS guidance raise of 2.5c.
Analyst Ana Gupte commented, "Importantly, the Consolidated MLR miss of 40 bps was underpinned by a meaningfully conservative incremental estimated loss in the ObamaCare... More
UnitedHealth (UNH) PT Raised to $160 at Mizuho Post Q2
July 19, 2016 3:28 PM EDTMizuho Securities analyst Sheryl Skolnick reiterating an Outperform rating and boosted her price target on UnitedHealth Group (NYSE: UNH) to $160.00 (from $156.00) following Q2 results.
"We see further upside to our new 2016/17 estimates and raise our PT to $160 from $156 as we see UNH's long-term earnings power... More
UnitedHealth Group (UNH) Tops Q2 EPS by 7c
July 19, 2016 6:13 AM EDTUnitedHealth Group (NYSE: UNH) reported Q2 EPS of $1.96, $0.07 better than the analyst estimate of $1.89. Revenue for the quarter came in at $46.5 billion versus the consensus estimate of $45.05 billion.
GUIDANCE:
UnitedHealth Group sees FY2016 EPS of $7.80-$7.95, versus the consensus of... More
UnitedHealth sees further losses for Obamacare insurance
July 19, 2016 6:12 AM EDTBy Caroline Humer
(Reuters) - UnitedHealth Group Inc (NYSE: UNH) is still losing money on the individual insurance business created under U.S. President Barack Obama's national healthcare reform law due to customers' high medical costs, the company said on Tuesday.
The largest U.S. health insurer said that it was booking $200 million in losses in the second quarter to cover higher-than-anticipated use of medical services by customers this year. UnitedHealth and other insurers have blamed those costs for their losses from the exchange business.
The company said it expected the program,... More
